Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNONW) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $3.4 million.

  • Tenon Medical's Cash & Equivalents fell 6243.18% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 6243.18%. This contributed to the annual value of $6.5 million for FY2024, which is 16915.16% up from last year.
  • Tenon Medical's Cash & Equivalents amounted to $3.4 million in Q3 2025, which was down 6243.18% from $7.8 million recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's Cash & Equivalents peaked at $10.3 million during Q1 2025, and registered a low of $2.0 million during Q2 2024.
  • For the 5-year period, Tenon Medical's Cash & Equivalents averaged around $5.0 million, with its median value being $3.9 million (2024).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 6637.05% in 2024, then skyrocketed by 29867.89% in 2025.
  • Tenon Medical's Cash & Equivalents (Quarter) stood at $2.9 million in 2021, then decreased by 27.01% to $2.1 million in 2022, then increased by 14.04% to $2.4 million in 2023, then surged by 169.15% to $6.5 million in 2024, then crashed by 47.33% to $3.4 million in 2025.
  • Its Cash & Equivalents was $3.4 million in Q3 2025, compared to $7.8 million in Q2 2025 and $10.3 million in Q1 2025.